Compare BridgeBio Pharma Inc (BBIO) vs Plug Power Inc (PLUG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Plug Power Inc — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Plug Power Inc trades at $2.3 (market cap $3.03B). The key difference: BridgeBio Pharma Inc is far larger — about 5.4× Plug Power Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Plug Power Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | PLUG | |
|---|---|---|
Market Cap | $16.27B | $3.03B |
Sector | Health | Industrials |
52-Week High | $90.17 | $4.14 |
52-Week Low | $44.81 | $1.40 |
Enterprise Value | $17.82B | $3.81B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Plug Power Inc
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.
Read more on PLUG →
